Kraig Biocraft Laboratories Inc (KBLB): Allergan is paying a stunning 500% premi...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: DimesForShares post# 192967

Tuesday, 06/23/2020 8:12:52 PM

Tuesday, June 23, 2020 8:12:52 PM

Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

https://www.marketwatch.com/story/allergan-is-paying-a-stunning-500-premium-to-buy-a-clinical-stage-biotech-2016-09-20

KBLB’s buyout will be NO LESS of a premium.

Keep Last Read

Replies (2) Next 10 Prev Next

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!